Safety of Ultrarush Immunotherapy for Insect Venom in Children
Author Information
Author(s): Alice Köhli-Wiesner, Lisbeth Stahlberger, Christian Bieli, Tamar Stricker, Roger Lauener
Primary Institution: University Children's Hospital Zurich
Hypothesis
The study aims to evaluate the safety and tolerance of ultrarush induction for specific venom immunotherapy in children.
Conclusion
Ultrarush immunotherapy for hymenoptera venom is safe and well tolerated in children.
Supporting Evidence
- All patients reached the cumulative dose of 111.1 μg hymenoptera venom within 210 minutes.
- Systemic adverse reactions occurred in 16% of patients, with no grade IV reactions.
- No systemic adverse reactions were observed in patients aged 4 to 8 years.
Takeaway
This study shows that giving allergy shots quickly to kids who are allergic to bee or wasp stings is safe and works well.
Methodology
Retrospective analysis of 102 ultrarush desensitizations in 94 children aged 4 to 15 years.
Potential Biases
Potential bias due to the retrospective nature of the study.
Limitations
The study did not include a control group for comparison.
Participant Demographics
94 children, aged 4 to 15 years, including 70 boys and 24 girls.
Statistical Information
P-Value
0.034
Confidence Interval
0.07–1.25
Statistical Significance
p=0.034
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website